Search

Your search keyword '"Plantefève G"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Plantefève G" Remove constraint Author: "Plantefève G"
89 results on '"Plantefève G"'

Search Results

1. COVA: results of a double-blind, placebo-controlled phase 2/3 study to assess efficacy and safety of BIO101 in hospitalized COVID-19 patients

2. Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units

3. Prognosis of Very Elderly Patients After Intensive Care

4. Evaluation of pulse pressure variation validity criteria in critically ill patients: a prospective observational multicentre point-prevalence study†

12. Prognostic significance of central venous-to-arterial carbon dioxide difference during the first 24 hours of septic shock in patients with and without impaired cardiac function

13. Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial

23. Liste des auteurs

24. Hydrocortisone in Severe Community-Acquired Pneumonia.

25. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

26. French Intensive Care Society, International congress – Réanimation 2016

29. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.

30. Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.

31. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.

32. Effectiveness of exercise training on the dyspnoea of individuals with long COVID: A randomised controlled multicentre trial.

34. Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients.

35. Purpura fulminans due to Enterococcus cecorum in an asplenic patient.

37. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.

38. Prognosis of Very Elderly Patients after Intensive Care.

39. Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry.

40. A Patient with Sepsis and Thickened Gastric Wall.

41. Lung Abscess in Critically Ill Coronavirus Disease 2019 Patients With Ventilator-Associated Pneumonia: A French Monocenter Retrospective Study.

45. Eosinophilia in critically ill COVID-19 patients: a French monocenter retrospective study.

46. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

47. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU.

48. Epidural analgesia in ICU chest trauma patients with fractured ribs: retrospective study of pain control and intubation requirements.

49. Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study.

50. A fatal fecaloma.

Catalog

Books, media, physical & digital resources